Literature DB >> 15616271

Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

James R Johnson1, Michael A Kuskowski, Timothy T O'bryan, Raul Colodner, Raul Raz.   

Abstract

To clarify the virulence and phylogenetic implications of antimicrobial agent resistance in Escherichia coli, 100 E. coli isolates from urine samples of Israeli women with acute uncomplicated cystitis were analyzed by molecular phylotyping and virulence genotyping for comparison with resistance phenotypes. The differences between the isolates that were resistant and susceptible to trimethoprim-sulfamethoxazole and ampicillin were minimal. In contrast, ciprofloxacin resistance was associated with greatly reduced inferred virulence and categorical shifts away from the highly virulent phylogenetic group B2, which explained much of the virulence effect. The results of amplification fingerprinting suggested that most ciprofloxacin-resistant isolates represented unique clonal groups and were not derived from clonal groups with more highly virulent susceptible isolates. These findings suggest that virulence and antimicrobial resistance are not mutually exclusive in E. coli clinical isolates. Instead, the relationship between virulence and antimicrobial resistance varies according to the particular resistance phenotype; for ciprofloxacin resistance, the relationship is strongly influenced by phylogenetic background. The basis for the concentration of ciprofloxacin resistance in non-B2 phylogenetic groups remains unknown.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616271      PMCID: PMC538882          DOI: 10.1128/AAC.49.1.26-31.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Clonal origin, virulence factors, and virulence.

Authors:  J R Johnson; M Kuskowski
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  The colonization of the human gut by antibiotic resistant Escherichia coli from chickens.

Authors:  A H Linton; K Howe; P M Bennett; M H Richmond; E J Whiteside
Journal:  J Appl Bacteriol       Date:  1977-12

3.  Epidemic multiresistant Escherichia coli infection in West Lambeth Health District.

Authors:  I Phillips; S Eykyn; A King; W R Gransden; B Rowe; J A Frost; R J Gross
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

Review 4.  Prevention of urinary tract infection.

Authors:  A Stapleton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 5.  Management of urinary tract infections in adults.

Authors:  W E Stamm; T M Hooton
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

6.  Urinary tract infection: self-reported incidence and associated costs.

Authors:  B Foxman; R Barlow; H D'Arcy; B Gillespie; J D Sobel
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

Review 7.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.

Authors:  A R Manges; J R Johnson; B Foxman; T T O'Bryan; K E Fullerton; L W Riley
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

9.  Are quinolone-resistant uropathogenic Escherichia coli less virulent?

Authors:  Jordi Vila; Karine Simon; Joaquin Ruiz; Juan P Horcajada; Maria Velasco; Margarita Barranco; Antonio Moreno; Josep Mensa
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

10.  Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.

Authors:  James R Johnson; Cindy van der Schee; Michael A Kuskowski; Wil Goessens; Alex van Belkum
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

View more
  26 in total

1.  Virulence factors in Escherichia coli.

Authors:  James R Johnson
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry.

Authors:  Timothy J Johnson; Catherine M Logue; James R Johnson; Michael A Kuskowski; Julie S Sherwood; H John Barnes; Chitrita DebRoy; Yvonne M Wannemuehler; Mana Obata-Yasuoka; Lodewijk Spanjaard; Lisa K Nolan
Journal:  Foodborne Pathog Dis       Date:  2011-10-11       Impact factor: 3.171

3.  Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.

Authors:  Johann D D Pitout; Kevin B Laupland; Deirdre L Church; Megan L Menard; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

Authors:  T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-03       Impact factor: 3.267

6.  In Vivo Transmission of an IncA/C Plasmid in Escherichia coli Depends on Tetracycline Concentration, and Acquisition of the Plasmid Results in a Variable Cost of Fitness.

Authors:  Timothy J Johnson; Randall S Singer; Richard E Isaacson; Jessica L Danzeisen; Kevin Lang; Kristi Kobluk; Bernadette Rivet; Klaudyna Borewicz; Jonathan G Frye; Mark Englen; Janet Anderson; Peter R Davies
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

7.  Virulence characteristics and phylogenetic background of ciprofloxacin resistant Escherichia coli in the urine samples from Korean women with acute uncomplicated cystitis.

Authors:  Chul Sung Kim; Min Eui Kim; Yong-Hyun Cho; In Rae Cho; Gilho Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

8.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

9.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

10.  European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Authors:  Simone Cagnacci; Laura Gualco; Eugenio Debbia; Gian Carlo Schito; Anna Marchese
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.